Intrinsic Value of S&P & Nasdaq Contact Us

Cerevel Therapeutics Holdings, Inc. CERE NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
22/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$33.50
-25.5%

Cerevel Therapeutics Holdings, Inc. (CERE) has 12 identified peers for comparison in the Healthcare sector. Peers include APLS, BPMC, CGEM, DAWN, DSGN, GLUE and others.

CERE has a market capitalization of $8.19B, compared to an average peer market cap of $2.67B. CERE is significantly larger than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message